2020-10-20
Our proprietary multiplex digital PCR (mdPCR™) technology breaks through the multiplexity limitation in current qPCR/dPCR methods, and enables multigene panel testing on a fully automated instrument for complex genetic disease diagnostics, early cancer detection, precision medicine, non-invasive prenatal screening, and infectious disease diagnosis。 We strive for “Democratizing Molecular Diagnostics”, and is dedicated to the commercialization of innovative IVD platform products to decentralize routine genetic testing。 We aim for enabling dynamic genetic health data for clinical research and routine genetic diagnostics, to fulfill the unmet medical needs in “Early Detection and Early Treatment“.
Look for: CRO/CMO/CDMO/OEM/ODM
Booth No. L405